Stock info Lexicon Pharmaceuticals | Filter  Basic-Info

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals is active in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year was a good year for Lexicon Pharmaceuticals investors

The stock gained over the past 12 months at around 27 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 138 percent. Lexicon Pharmaceuticals's revenues between 2011 and 2015 were very fluctuating and moved between 1,09 million dollars and 130,01 million dollars. Lexicon Pharmaceuticals's net incomes between 2011 and 2015 were very volatile and moved between -116,22 million dollars and -4,68 million dollars.

Over the past 5 years the American company paid out dividends.

Lexicon Pharmaceuticals financed with a quite low debt position

At the end of 2015 the American company had a balance sheet of around 654,83 million dollars. The total debt was around 368,98 million dollars. This is 56,35 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around -637. So investors paid -637 times the company's 2015's EPS. We could say that based on it's price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 1,36 billion dollars. At the end of 2015 the American company had around 103,59 million stocks listed on the exchanges.

All the company's financial reports are available here. More information about Lexicon Pharmaceuticals can be found it's website. .